21st.BIO has earned a self-affirmed GRAS status for its animal-free beta-lactoglobulin ingredient, which customers can now launch in the United States…
SHANGHAI, Sept. 3, 2024 /PRNewswire/ — A news report from english.shanghai.gov.cn: The legislature of Shanghai passed revised regulations on August 22 to…
VES001 is a first-in-class oral, brain penetrant, small molecule sortilin inhibitor for treatment of FTD(GRN) Data demonstrate excellent safety, tolerability…